Integrating genetic approaches into the discovery of anticancer drugs.
暂无分享,去创建一个
L. Hartwell | A. Murray | C. J. Roberts | S. Friend | P. Szankasi | L. Hartwell | Leland Hartwell | A. Murray
[1] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[2] P. Jeggo,et al. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. , 1989, Cancer research.
[3] I. Pastan,et al. Expression of Multidrug Resistance Gene in Human Cancers , 1989 .
[4] M. Marshall,et al. The ras oncogene--an important regulatory element in lower eucaryotic organisms , 1989, Microbiological reviews.
[5] Y. Yamaoka,et al. O6-methylguanine-DNA methyltransferase activity in human liver tumors. , 1991, Carcinogenesis.
[6] J. Broach,et al. Ras-regulated signaling processes in Saccharomyces cerevisiae. , 1991, Current opinion in genetics & development.
[7] M. Ikenaga,et al. O6-methylguanine-DNA methyltransferase activity in human tumors. , 1992, Carcinogenesis.
[8] I. Herskowitz,et al. Learning about cancer genes through invertebrate genetics. , 1992 .
[9] L. Johnston,et al. Pathway correcting DNA replication errors in Saccharomyces cerevisiae. , 1993, The EMBO journal.
[10] Loss of chromosomal integrity in neoplasia. , 1993, Cold Spring Harbor symposia on quantitative biology.
[11] Game Jc. DNA double-strand breaks and the RAD50-RAD57 genes in Saccharomyces. , 1993 .
[12] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[13] R. Comis. Cisplatin: the future. , 1994, Seminars in oncology.
[14] P. Sternberg,et al. Molecular genetics of proto-oncogenes and candidate tumor suppressors in Caenorhabditis elegans. , 1994, Cold Spring Harbor symposia on quantitative biology.
[15] L. Hartwell,et al. Cell cycle control and cancer. , 1994, Science.
[16] H. Horvitz,et al. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.
[17] E. Hurt,et al. Genetic approaches to nuclear pore structure and function. , 1995, Trends in genetics : TIG.
[18] D. Louis,et al. A tiger behind many doors: multiple genetic pathways to malignant glioma. , 1995, Trends in genetics : TIG.
[19] M. Meyn,et al. Ataxia-telangiectasia and cellular responses to DNA damage. , 1995, Cancer research.
[20] J. Sekelsky,et al. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene , 1995, Cell.
[21] P. Sternberg,et al. Ras pathways in Caenorhabditis elegans. , 1995, Current opinion in genetics & development.
[22] E. Louis,et al. Sgs1: A eukaryotic homolog of E. coil RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation , 1995, Cell.
[23] Gillian Smith,et al. Metabolic polymorphisms and cancer susceptibility. , 1995, Cancer surveys.
[24] L. Dirick,et al. Roles and regulation of Cln‐Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae. , 1995, The EMBO journal.
[25] K. Goa,et al. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia. , 1996, Drugs & aging.
[26] G. Ojemann,et al. Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] José Alberola-lla,et al. The use of dominant-negative mutations to elucidate signal transduction pathways in lymphocytes. , 1996, Current opinion in immunology.
[28] R. Myers,et al. Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.
[29] E. Louis,et al. SGS1, a homologue of the Bloom's and Werner's syndrome genes, is required for maintenance of genome stability in Saccharomyces cerevisiae. , 1996, Genetics.
[30] D. Stinchcomb,et al. Anti-gene therapy: the use of ribozymes to inhibit gene function. , 1996, Trends in genetics : TIG.
[31] J. Hoeijmakers,et al. TFIIH: a key component in multiple DNA transactions. , 1996, Current opinion in genetics & development.
[32] K. Nasmyth. At the heart of the budding yeast cell cycle. , 1996, Trends in genetics : TIG.
[33] R. Brent,et al. Isolation of Drosophila cyclin D, a protein expressed in the morphogenetic furrow before entry into S phase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Murray,et al. The spindle assembly checkpoint. , 1996, Current opinion in cell biology.
[35] M. Vidal,et al. RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. , 1996, Genes & development.
[36] D. Lydall,et al. From DNA damage to cell cycle arrest and suicide: a budding yeast perspective. , 1996, Current opinion in genetics & development.
[37] T. Jacks,et al. Mechanisms of carcinogenesis and the mutant mouse. , 1996, Current opinion in genetics & development.
[38] R. Eisenman,et al. Myc and Max Homologs in Drosophila , 1996, Science.
[39] C. Sherr. Cancer Cell Cycles , 1996, Science.
[40] B. Edgar,et al. Developmental Control of Cell Cycle Regulators: A Fly's Perspective , 1996, Science.
[41] Stephen J. Elledge,et al. Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.
[42] R. Kolodner,et al. Biochemistry and genetics of eukaryotic mismatch repair. , 1996, Genes & development.
[43] C. Lawrence,et al. Deoxycytidyl transferase activity of yeast REV1 protein , 1996, Nature.
[44] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[45] K. Kinzler,et al. Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients , 1996, Nature Medicine.
[46] S. Agrawal,et al. Antisense oligonucleotides: towards clinical trials. , 1996, Trends in biotechnology.
[47] Yuko Yamaguchi-Iwai,et al. Reduced X-Ray Resistance and Homologous Recombination Frequencies in a RAD54−/− Mutant of the Chicken DT40 Cell Line , 1997, Cell.
[48] J. Masters,et al. DNA Repair capacity and cisplatin sensitivity of human testis tumour cells , 1997, International journal of cancer.
[49] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[50] T. Jacks,et al. Double indemnity: p53, BRCA and cancer , 1997, Nature Medicine.
[51] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[52] K. Kinzler,et al. Genetic instability in colorectal cancers , 1997, Nature.
[53] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[54] A. Carr,et al. rqh1+, a fission yeast gene related to the Bloom‘s and Werner's syndrome genes, is required for reversible S phase arrest , 1997, The EMBO journal.
[55] James M. Roberts,et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.
[56] A. Carr. Control of cell cycle arrest by the Mec1sc/Rad3sp DNA structure checkpoint pathway. , 1997, Current opinion in genetics & development.
[57] D A Sinclair,et al. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. , 1997, Science.
[58] N. Ellis. DNA helicases in inherited human disorders. , 1997, Current opinion in genetics & development.